Brentuximab Vedotin in Combination with RCHOP As Front-Line Therapy in Patients with DLBCL: Interim Results from a Phase 2 Study Yasenchak, C. A., Farber, C. M., Budde, L., Ansell, S. M., Advani, R., Holkova, B., Halwani, A., Knapp, M., Fayad, L., Kolibaba, K. S., Patel-Donnelly, D., Seetharam, M., Manley, T. J., Bartlett, N. L. AMER SOC HEMATOLOGY. 2014

View details for Web of Science ID 000349242703137